Psychopathological and peripheral levels of neurobiological correlates of obsessive-compulsive symptoms in patients with epilepsy: A hospital-based study

Epilepsy and Behavior

Volumn 27, Issue 2, 2013, Pages 409-415

  Hamed, Sherifa A ^a   Elserogy, Yasser M ^a   Abd ElHafeez, Heba A ^b  

^a ASSIUT UNIVERSITY   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

Adrenaline; Antiepileptic drugs; Dopamine; Epilepsy; Noradrenaline; Obsessive compulsive symptoms; Serotonin

Indexed keywords

ADRENALIN; DOPAMINE; NORADRENALIN; SEROTONIN;

ADRENALIN BLOOD LEVEL; ADULT; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DOPAMINE BLOOD LEVEL; DSM-IV; FEMALE; GENERALIZED EPILEPSY; HAMILTON ANXIETY SCALE; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NEUROBIOLOGY; NORADRENALIN BLOOD LEVEL; OBSESSIVE COMPULSIVE DISORDER; SEROTONIN BLOOD LEVEL; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADULT; ANTICONVULSANTS; BIOGENIC MONOAMINES; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84876106559     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2013.01.022     Document Type: Article

References (55)

1. Hauser W.A. Incidence and prevalence. Epilepsy: a comprehensive textbook 1997, 47-57. Lippincott-Raven, Philadelphia. J. Engel, T.A. Pedley (Eds.).
2. Engel J. Etiology as a risk factor for medically refractory epilepsy: a case for early surgical intervention. Neurology 1998, 51:1243-1244.
3. Hamed S.A. Neuroendocrine hormonal conditions in epilepsy: relationship to reproductive and sexual functions. Neurologist 2008, 14:157-169.
4. Hamed S.A. The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications. CNS Neurosci Ther 2009, 15:134-156.
5. Hamed S.A. Psychiatric symptomatology and disorders related to epilepsy and antiepileptic medications. Expert Opin Drug Saf 2011, 10:913-934.
6. Swinkels W.A., van Emde Boas W., Kuyk J., van Dyck R., Spinhoven P. Interictal depression, anxiety, personality traits, and psychological dissociation in patients with temporal lobe epilepsy (TLE) and extra-TLE. Epilepsia 2006, 47:2092-2103.
7. Mula M., Monaco F. Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord 2009, 11:1-9.
8. Hamed S.A., Metwaly N.A., Hassan M.M., et al. Depression in adults with epilepsy: relationship to psychobiological variables. World J Neurol 2012, 2(1):1-10.
9. Hamed S.A., Elserogy Y.E., Abdou M.A., Abdellah M.M. The risks of suicidality in adult patients with epilepsy. World J Psychiatry 2012, 2:33-42.
10. Isaacs K.L., Philbeck J.W., Barr W.B., Devinsky O., Alper K. Obsessive-compulsive symptoms in patients with temporal lobe epilepsy. Epilepsy Behav 2004, 5:569-574.
11. Monaco F., Cavanna A., Magli E., et al. Obsessionality, obsessive-compulsive disorder, and temporal lobe epilepsy. Epilepsy Behav 2005, 7:491-496.
12. Ertekin B.A., Kulaksizoǧlu I.B., Ertekin E., et al. A comparative study of obsessive-compulsive disorder and other psychiatric comorbidities in patients with temporal lobe epilepsy and idiopathic generalized epilepsy. Epilepsy Behav 2009, 14:634-639.
13. Kaplan P.W. Epilepsy and obsessive-compulsive disorder. Dialogues Clin Neurosci 2010, 12:241-248.
14. Karno M., Golding J.M., Sorenson S.B., Burnam M.A. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988, 45:1094-1099.
15. Kwon J.S., Kim J.J., Lee D.W., et al. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res 2003, 122:37-47.
16. van den Heuvel O.A., Veltman D.J., Groenewegen H.J., et al. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry 2005, 62:301-309.
17. Kalinin V.V., Polyanskiy D.A. Focus, laterality and interictal psychiatric disorder in temporal lobe epilepsy. Seizure 2009, 18:176-179.
18. Maia A.F., Pinto A.S., Barbosa E.R., Menezes P.R., Miguel E.C. Obsessive-compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2003, 15:371-374.
19. Kivircik B.B., Yener G.G., Alptekin K., Aydin H. Event-related potentials and neuropsychological tests in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:601-606.
20. Mula M., Cavanna A.E., Critchley H., Robertson M.M., Monaco F. Phenomenology of obsessive compulsive disorder in patients with temporal lobe epilepsy or Tourette syndrome. J Neuropsychiatry Clin Neurosci 2008, 20:223-226.
21. Koopowitz L.F., Berk M. Response of obsessive compulsive disorder to carbamazepine in two patients with comorbid epilepsy. Ann Clin Psychiatry 1997, 9:171-173.
22. Kanner A.M., Morris H.H., Stagno S., Chelune G., Luders H. Remission of an obsessive-compulsive disorder following a right temporal lobectomy. Neuropsychiatry Neuropsychol Behav Neurol 1993, 6:126-129.
23. Togao O., Yoshiura T., Nakao T., et al. Regional gray and white matter volume abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Psychiatry Res 2010, 184:29-37.
24. Kulaksizoglu I.B., Bebek N., Baykan B., et al. Obsessive-compulsive disorder after epilepsy surgery. Epilepsy Behav 2004, 5:113-118.
25. Barbieri V., Lo Russo G., Francione S., Scarone S., Gambini O. Association of temporal lobe epilepsy and obsessive-compulsive disorder in a patient successfully treated with right temporal lobectomy. Epilepsy Behav 2005, 6:617-619.
26. Guarnieri R., Araújo D., Carlotti C.G., et al. Suppression of obsessive-compulsive symptoms after epilepsy surgery. Epilepsy Behav 2005, 7:316-319.
27. Roth R.M., Jobst B.C., Thadani V.M., Gilbert K.L., Roberts D.W. New-onset obsessive-compulsive disorder following neurosurgery for medication-refractory seizure disorder. Epilepsy Behav 2009, 14:677-680.
28. Berg A.T., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51:676-685.
29. Hamed S.A., Hamed E.A., Kandil M.R., El-Shereef H.K., Abdellah M.M., Omar H. Serum thyroid hormone balance and lipid profile in patients with epilepsy. Epilepsy Res 2005, 66:173-183.
30. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, 317-391. American Psychiatric Association, Washington, DC. 4th ed.
31. Sheehan D.V., Lecrubier Y., Sheehan K.H., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl. 20):22-33.
32. Gharyb A.G. Beck Depression Inventory II (BDI-II): Arabic examiner's hand book 2000, Dar El-Anglo, Cairo.
33. Beck A.T., Steer R.A., Ball R., Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 1996, 7:588-597.
34. Lotfy F. Hamilton Anxiety Rating Scale (HAM-A): Arabic translated version 1994, Dar El-Anglo, Cairo.
35. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50-55.
36. Mohamed M. Yale-Brown Obsessive Compulsive Scale: Arabic translated version 2010, Dar El-Anglo, Cairo.
37. Goodman W.K., Price L.H., Rasmussen S.A., et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use, and reliability. Arch Gen Psychiatry 1989, 46:1006-1011.
38. Melika L.K. Wechsler Adult Intelligence Scale-revised manual. Arabic examiner's handbook 1996, Dar Egyptian Books House, Cairo.
39. Wechsler D. WAIS-R manual. Wechsler Adults Intelligence Scale-revised 1981, New York Harcourt.
40. Kobau R., Gilliam F., Thurman D.J. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Health Styles Survey. Epilepsia 2006, 47:1915-1921.
41. Beyenburg S., Mitchell A.J., Schmidt D., Elger C.E., Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav 2005, 7:161-171.
42. Kanner A.M. Recognition of the various expressions of anxiety, psychosis and aggression in epilepsy. Epilepsia 2004, 45:22-27.
43. Christensen J., Vestergaard M., Mortensen P.B., Sidenius P., Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007, 6:693-698.
44. Richardson E.J., Griffith H.R., Martin R.C., et al. Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy. Epilepsy Behav 2007, 10:242-249.
45. Weissman M.M., Bland R., Joyce P.R., Newman S., Wells J.E., Wittchen H.U. Sex differences in rates of depression: cross-national perspectives. J Affect Disord 1993, 29:77-84.
46. Kessler R.C., McGonagle K.A., Zhao S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
47. Perrine K., Hermann B.P., Meador K.J., Vickrey B.G., Cramer J.A., Hays R.D. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995, 52:997-1003.
48. Berthier M.L., Kulisevsky J., Gironell A., Heras J.A. Obsessive-compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function, and anatomic correlates. Neurology 1996, 47:353-361.
49. Karch S., Pogarell O. Neurobiology of obsessive-compulsive disorder. Nervenarzt 2011, 82:299-307.
50. Greist J.H., Jefferson J.W., Kobak K.A., Katzelnick D.J., Serlin R.C. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta-analysis. Arch Gen Psychiatry 1995, 52:53-60.
51. Sansone R.A., Sansone L.A. SNRIs pharmacological alternatives for the treatment of obsessive compulsive disorder?. Innov Clin Neurosci 2011, 8:10-14.
52. Dell'Osso B., Mundo E., Marazziti D., Altamura A.C. Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive-compulsive disorder: a case series. J Psychopharmacol 2008, 22:210-213.
53. Denys D., Zohar J., Westenberg H.G. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. J Clin Psychiatry 2004, 65(Suppl. 14):11-17.
54. Kim C.H., Cheon K.A., Koo M.S., et al. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT. SPECT before and after treatment with serotonin reuptake inhibitors. Neuropsychobiology 2007, 55:156-162.
55. Adams K.H., Hansen E.S., Pinborg L.H., et al. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 2005, 8:391-401.